June 1, 2003European Journal of Heart Failure Supplements
The pathophysiological basis of anaemia in chronic heart failure
Population
Patients with chronic heart failure and anaemia
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports anaemia evaluation in heart failure; leaves open erythropoietin efficacy pending randomized trials.
Structured PICO
P
Population
Patients with chronic heart failure and anaemia
I
Intervention
Erythropoietin therapy
Anaemia is a common, multifactorial complication in chronic heart failure associated with poor prognosis, and erythropoietin therapy may offer a potential therapeutic avenue.
Cite This Study
Andrew J.S. Coats (2003) studied this question.